Managing type 2 diabetes while reducing cardiovascular risk – is it possible? – ACRRM

After completing this education module, participants will have increased confidence in:

1. Recognising the differences between microvascular and macrovascular complications as they relate to glycaemic control.
2. Differentiating between the cardiovascular outcomes associated with newer hypoglycaemic agents and applying this to clinical practice.
3. Individualising diabetes treatment protocols based on patients’ risk profiles and comorbidities.
4. Identifying clinical situations in which certain antihyperglycaemic medications may be contraindicated or require cessation.